Position history for MARSHALL WACE, LLP's holdings in Tango Therapeutics, Inc.
MARSHALL WACE, LLP holds 329,231 shares of TNGX (Tango Therapeutics, Inc.), worth $2.9M as of 2025-Q4. The position was decreased (-77.9% shares). TNGX represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$2.9M
Current Shares
329,231
Total Value Change
+$2M
Total Shares Change
+219,962
Other major holders of TNGX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, FARALLON CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.
Decreased |
| 329,231 |
-77.9% |
| $2.9M |
| 0.0% |
| $8.63 |
0 |
| 2025-Q3 | Decreased | 1.5M | -14.5% | $12.5M | 0.0% | $8.44 | 0 |
| 2025-Q2 | Decreased | 1.7M | -5.4% | $8.9M | 0.0% | $5.01 | 0 |
| 2025-Q1 | New | 1.8M | - | $2.5M | 0.0% | $1.47 | 36 |
| 2024-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $3.10 | 0 |
| 2024-Q3 | New | 73,122 | - | $563,040 | 0.0% | $7.47 | 34 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $8.58 | 0 |
| 2024-Q1 | New | 109,269 | - | $867,596 | 0.0% | $7.94 | 34 |